💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

US STOCKS-Wall St up on 'buy the dip,' data signals Fed's move

Published 09/28/2010, 02:00 PM
Updated 09/28/2010, 02:04 PM

* Consumer confidence worse than expected, home prices dip

* Apple slides at open, then cuts losses

* Walgreen jumps after earnings

* Dow up 0.5 pct, S&P up 0.5 pct, Nasdaq up 0.4 pct

* For up-to-the-minute market news see [STXNEWS/US] (Updates to early afternoon)

By Rodrigo Campos

NEW YORK, Sept 28 (Reuters) - U.S. stocks rose on Tuesday after opening lower on weak economic data, with investors saying the data bolsters expectations the Fed will pump more money into the economy, which would support equities.

The S&P 500 has risen about 9 percent so far in September, making it one of the best months for the index in 20 years.

Some of the strength in equities "is related to the fact the Fed's been signaling they're going to be easy and some of the short-term economic data probably doesn't matter that much," said Perry Piazza, director of investment strategy at Contango Capital Advisors in San Francisco.

"Everybody expected seasonal weakness in September and they're not getting it so they're forced to hop on board the rally," he said. "People are buying dips."

U.S. Treasury debt prices also rose, as the weaker-than expected data increased expectations that the Fed will give the economy more support.

But the recent rally in bonds could be a bubble, Byron Wien, the vice chairman of Blackstone Advisory Partners, told Reuters Insider. He sees stocks moving higher, with little chance of another recession. http://link.reuters.com/nyn74p

The Dow Jones industrial average <.DJI> gained 55.10 points, or 0.51 percent, to 10,867.14. The Standard & Poor's 500 <.SPX> rose 5.39 points, or 0.47 percent, to 1,147.55. The Nasdaq Composite <.IXIC> added 9.24 points, or 0.39 percent, to 2,379.01.

Walgreen Co , the biggest U.S. drugstore chain, reported higher-than-expected quarterly earnings, helped by strong prescription drug sales. Its shares jumped 12.3 percent to $33.95. [ID:nN28124290]

Continuing the spurt of recent M&A activity, Endo Pharmaceuticals Holdings Inc will buy private generics maker Qualitest Pharmaceuticals for about $1.2 billion, marking its second deal in as many months. Endo shares advanced 8.4 percent to $33.17.

September data showed U.S. consumer confidence fell to its lowest level since February, underscoring lingering worries about the strength of the economic recovery, while home prices dipped in July. [ID:nN28177460]

Shares of Apple Inc slid as much as 5.6 percent on rumors its No. 2 executive was departing for Hewlett-Packard Co , but the stock recovered as analysts dismissed the speculation. [ID:nN28185533].

Representatives from Apple and Hewlett-Packard declined to comment. Apple shares shed 1 percent to $288.30 and HP rose 1.1 percent to $41.72. (Reporting by Rodrigo Campos; Editing by Jan Paschal)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.